FDA Inspections

Immunomedics Recent FDA Inspection and Impact on their NDA Approval

After fifteen years of zero FDA enforcement activity, Immunomedics was hit hard not once, but twice in one month. The second punch was concerning enough to thrust them into the spotlight, causing their stock to be sold and their shares to plummet.